Completed NA INTERVENTIONAL 3-arm NCT03272750

Evaluation of Tolerance and Trichological Efficacy of a Food Supplement

Controlled, Randomized, Double Blind Study, for the Evaluation of Tolerance and Trichological Efficacy of a Food Supplement: Bioscalin® New Formulation Versus Reference Formulation Currently on the Market and Placebo

Sponsor: Derming SRL

Conditions Telogen Effluvium

Interventions Bioscalin® new formulation with Galeopsis Segetum Placebo Reference product

Updated 4 times since 2017 Last updated: Sep 1, 2017 Started: Nov 4, 2016 Primary completion: Mar 31, 2017 Completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03272750, this NA trial focuses on Telogen Effluvium and remains completed. Sponsored by Derming SRL, it has been updated 4 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Derming SRL

Data source: Derming SRL

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.